Bid Banana
PricingBid helpAPILog inStart free trial
Log inStart free trial

Learn more

  • Federal contracts (SAM.gov)The Ultimate Guide to SAM.gov Registration
  • Healthcare RFPsHealthcare and Medical Services Bids and Bidding Guide
More healthcare and medical services bids →Must-win bid? Bring in The Bid Lab →
Bid Banana
SearchPricingBid helpBrowse bidsAPISupportFAQPrivacy PolicyTerms of UseAI Use Policy

This website and its content is copyright of The Bid Lab © 2026. The Bid Lab is a trademark of Bid Lab, LLC. All rights reserved.

  1. Bid Banana
  2. ›Closed bids
  3. ›Federal
  4. ›NxTAG Respiratory Pathogen Panel

U.S. Department Of Defense·California

NxTAG Respiratory Pathogen Panel

Closes 2/16/2026$100k – $500kSole Source
Bid source

This opportunity has closed.

Bid Banana tracks 1.6M+ bids and awards across all 50 states. Save a search and we'll email your new matches, daily or weekly — so the next one reaches you with time to bid.

Get alerted next time

Description

The Naval Health Research Center (NHRC) intends to award a sole-source contract to DIASORIN MOLECULAR, LLC for the NxTAG Respiratory Pathogen Panel v2 (IVD - US) 96 TESTS. The contract is for the procurement of kits, with a part number of I055C0465. The delivery schedule includes multiple dates from March 3, 2026, to July 7, 2026, with 4 kits to be delivered on each date. The minimum expiration date from shipment is 6 months, with an average of 7.4 months. All contractors must be registered in the System for Award Management (SAM.gov) and have fully completed FAR and DFARS representations and certifications. • The contract is for a specific product, the NxTAG Respiratory Pathogen Panel v2 (IVD - US) 96 TESTS. • The contract is a sole-source procurement, with the statutory authority being 10 U.S.C. 3204(a)(1) via FAR 6.302-1(b)(1)(ii). • The delivery schedule includes multiple dates, with 4 kits to be delivered on each date. • The minimum expiration date from shipment is 6 months, with an average of 7.4 months.

Attached files

The solicitation documents live at the source — open the bid source above to download them.

Contact

David L. Hill

[email protected]

Key dates

Opened
2/9/2026
Closes
2/16/2026

Last updated

Details

Type
Sole Source
Industry
Healthcare and Medical Services
NAICS
325413
Solicitation №
N6311626Q0515

Budget estimate

$100,000 – $500,000

The budget for this contract is likely to be in the range of $100,000 to $500,000, based on the procurement of a specific product, the NxTAG Respiratory Pathogen Panel v2 (IVD - US) 96 TESTS. The delivery schedule includes multiple dates, with 4 kits to be delivered on each date, which suggests a moderate to large-sized contract. The minimum expiration date from shipment is 6 months, with an average of 7.4 months, which may also impact the budget. However, without more information on the pricing of the product, it is difficult to provide a more accurate estimate.

AI estimate from the solicitation

Similar opportunities

Matched by Bid Banana AI™

Bid Banana · 1.6M+ bids and awards 🍌

You found this one too late. Don't find the next one too late.

Bid Banana searches open government bids across all 50 states, updated daily. Save a search once and we email you your new matches, daily or weekly, while there is still time to win them.

1.6M+
bids & awards
All 50
states
4,000+
agencies
Start your 7-day free trial

Plans from $49.99/month. Cancel anytime, no setup fees.

Built by The Bid Lab, answering RFPs since 2017.

U.S. National Institutes of Health·United States of America

Top match · 60%

NIAID Investigator Initiated Program Project Applications (P01 Clinical Trial Not Allowed)

Closes 5/25/2029Opened 6/16/2025

U.S. Centers for Disease Control and Prevention - ERA·United States of America

60% match

Improving Protection against Influenza and Other Respiratory Pathogens: the US Flu VE Network

Closes 1/29/2027Opened 7/28/2026

U.S. National Institutes of Health·United States of America

59% match

Infectious Diseases Clinical Trials Network (IDCTN) (UM1 Clinical Trial Required)

Closes 11/10/2026Opened 11/18/2025

U.S. National Institutes of Health·United States of America

59% match

Development of Candidate Medical Countermeasures (MCMs) and Technologies Against Radiological/Nuclear or Chemical Threats (U01 Clinical Trial Not Allowed)

Closes 10/9/2028Opened 4/9/2026

U.S. Department Of Energy·Ohio

57% match

TECHNOLOGY LICENSING OPPORTUNITY: Bacterial Lipid Nanodiscs Platform

Closes 12/15/2026Opened 6/15/2026

U.S. Department of Homeland Security - FEMA·United States of America

57% match

Fiscal Year 2026 BioWatch Grant Program

Rolling / TBD closeOpened 7/15/2026

U.S. National Institutes of Health·United States of America

57% match

Partnerships for Advancing Development of Diagnostics for Infectious Diseases

Closes 10/13/2027Opened 9/24/2026

U.S. Department Of Health And Human Services·Maryland

57% match

Clinical Research Support and Collaboration for NHGRI Protocols

Closes 11/13/2026Opened 10/26/2026

U.S. National Institutes of Health·United States of America

57% match

Translational Centers Using Microphysiological Systems for Infectious Diseases (U54 Clinical Trial Not Allowed)

Closes 1/29/2027Opened 6/24/2026

U.S. National Institutes of Health·United States of America

57% match

Limited Competition: Superfund Hazardous Substance Research and Training Program (P42 Clinical Trial Optional)

Closes 9/25/2028Opened 6/9/2025

U.S. National Institutes of Health·United States of America

57% match

Precision and Systems Biology to Uncover the Link Between Chronic and Infectious Diseases

Closes 1/21/2027Opened 6/24/2026

U.S. National Institutes of Health·United States of America

57% match

Limited Competition: Resources and Workforce Development for the Regional Biocontainment Laboratories

Closes 9/29/2027Opened 6/24/2026

U.S. Department Of Health And Human Services·United States of America

57% match

2027 NIAID DMID Omnibus Broad Agency Announcement: Development of Medical Interventions for Infectious Diseases

Closes 12/8/2026Opened 10/9/2026

U.S. National Institutes of Health·United States of America

56% match

Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)

Closes 6/3/2027Opened 7/14/2026

U.S. National Institutes of Health·United States of America

56% match

CCRP Initiative: Promoting a Basic Understanding of Chemical Threats to Skin (R01 Clinical Trial Not Allowed)

Closes 11/5/2028Opened 6/30/2025

U.S. Centers for Disease Control and Prevention - ERA·United States of America

56% match

Emerging Infections Network - Research for Preventing, Detecting, and Managing Travel-associated Infectious Diseases

Closes 11/5/2026Opened 8/1/2025

U.S. National Institutes of Health·United States of America

56% match

Carcinogen Hazard Assessment Monographs Program (CHAMP) (R01 Clinical Trial Not Allowed)

Closes 2/9/2027Opened 11/21/2025

U.S. National Institutes of Health·United States of America

56% match

Pilot Studies of Biological, Behavioral and Social Mechanisms Contributing to HIV Pathogenesis Within the Mission of NIDDK (R21 Clinical Trial Not Allowed)

Closes 11/16/2027Opened 1/8/2025

U.S. National Institutes of Health·United States of America

56% match

Integrated Specific Pathogen Free Research Models and Human New Approach Methodologies to Advance HIV/AIDS Research (U42 Clinical Trial Not Allowed)

Closes 1/24/2027Opened 5/20/2026

U.S. National Institutes of Health·United States of America

56% match

Specialized Programs of Research Excellence (SPOREs) in Human Cancers for Years 2027, 2028, and 2029 (P50 Clinical Trial Required)

Closes 9/25/2029Opened 9/9/2025

U.S. National Institutes of Health·United States of America

56% match

Translational Transplantation Tolerance Cooperative Study Group

Closes 5/20/2027Opened 6/24/2026

U.S. Food and Drug Administration·United States of America

56% match

NARMS Cooperative Agreement Program to Strengthen Antibiotic Resistance Surveillance in Retail Food Specimens

Rolling / TBD closeOpened 11/5/2024

U.S. National Institutes of Health·United States of America

56% match

Pancreatic Cancer Detection Consortium: Research Units (U01 Clinical Trial Optional)

Closes 11/5/2029Opened 2/11/2026

U.S. National Institutes of Health·United States of America

56% match

Limited Competition: The NHGRI Analysis, Visualization, and Informatics Lab-space (AnVIL) (U54 Clinical Trial Not Allowed)

Closes 5/24/2027Opened 6/2/2026

U.S. Centers for Disease Control - NCEZID·United States of America

56% match

DHQP Global NOFO

Closes 6/18/2027Opened 8/3/2026